MTLS MATERIALISE NV
Price Chart
Executive Summary
Materialise NV filed its annual management report and AGM notice for the June 16, 2026 meeting. FY2025 results show flat total revenue growth of 0.3% to €267.6M, with a strong 15.4% increase in the high-margin Medical segment offset by a 13.2% decline in Manufacturing and a 6.8% drop in Software. Net profit fell 42% to €7.7M from €13.4M, though Adjusted EBITDA grew 2.8% to €32.4M. The company completed its Euronext Brussels listing, authorized a €30M share buyback (€2.5M executed through April 2026), and fully remediated prior material weaknesses in internal controls. The RapidFit divestiture was immaterial.
Actionable Insight
The Medical segment's accelerating growth (15.4%) and margin expansion (32.0% Adj. EBITDA) are the key positive, but the Manufacturing segment's swing to negative EBITDA and Software's revenue decline are headwinds. The €30M buyback authorization and strong cash position provide downside support. Monitor Q1 2026 results for Manufacturing stabilization and Medical momentum — the AGM on June 16 is a non-event.
Key Facts
- FY2025 revenue flat at €267.6M (+0.3% YoY); Medical segment grew 15.4% to €134.2M, Manufacturing fell 13.2% to €92.5M, Software fell 6.8% to €40.9M
- Net profit declined 42% to €7.7M from €13.4M; Adjusted EBITDA rose 2.8% to €32.4M
- Medical segment Adjusted EBITDA margin expanded to 32.0% from 30.6%; Manufacturing segment turned negative at -4.6% from +1.6%
- Cash and equivalents increased €31.6M to €133.9M; total debt rose €23.9M to €57.5M
- Material weaknesses in internal controls fully remediated during 2025
- Share buyback program authorized Nov 2025; 545,529 shares repurchased for €2.5M through April 2026
- RapidFit subsidiary divestiture completed at carrying value — no material gain/loss
- Board and management hold 73.4% of voting rights as of April 2026
Financial Impact
Revenue flat at €267.6M; net profit down 42% to €7.7M; Adjusted EBITDA up 2.8% to €32.4M; cash +€31.6M to €133.9M
Risk Factors
- Manufacturing segment continued weakness from macro headwinds and capacity reduction
- Software segment transition to cloud/subscription model may pressure near-term revenue
- Increased debt (€57.5M, up €23.9M) and net financial expense swing from +€4.7M to -€1.6M
- Foreign exchange volatility impacting reported results
Market Snapshot
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-062479 |
| Document: tm2614525d1_6k.htm | 0001104659-26-062479 |
| Document: tm2614525d1_ex99-1.htm | 0001104659-26-062479 |
| Document: 0001104659-26-062479-index-headers.html | 0001104659-26-062479 |
| Document: 0001104659-26-062479-index.html | 0001104659-26-062479 |
| Document: 0001104659-26-062479.txt | 0001104659-26-062479 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 1, 2026
8d ago
|
6-K
| $6.89 $6.61 | ▼ −4.06% | ▼ −3.37% | $6.61 (−4.06%) |
|
May 18, 2026
22d ago
|
6-K
| $5.56 $5.66 | ▲ +1.80% | ▲ +0.76% | $6.61 (+18.88%) |
|
May 15, 2026
25d ago
|
6-K
| $5.61 $5.56 | ▼ −0.89% | ▼ −0.24% | $6.61 (+17.83%) |
|
May 8, 2026
4w ago
|
6-K
| $5.41 $5.47 | ▲ +1.11% | ▲ +0.88% | $6.61 (+22.18%) |
|
May 7, 2026
4w ago
|
6-K
| $5.41 $5.47 | ▲ +1.11% | ▲ +0.88% | $6.61 (+22.18%) |
|
Apr 27, 2026
6w ago
|
6-K
| $5.30 $5.25 | ▼ −0.94% | ▼ −0.93% | $6.61 (+24.72%) |
|
Apr 23, 2026
6w ago
|
6-K
| $5.21 $5.31 | ▲ +1.92% | ▲ +1.76% | $6.61 (+26.87%) |
|
Apr 23, 2026
6w ago
|
20-F
| $5.21 $5.31 | ▲ +1.92% | ▲ +1.76% | $6.61 (+26.87%) |
|
Apr 20, 2026
7w ago
|
6-K
| $5.39 $5.46 | ▲ +1.30% | ▲ +0.28% | $6.61 (+22.63%) |
|
Apr 13, 2026
8w ago
|
6-K
| $5.20 $5.31 | ▲ +2.12% | ▲ +1.34% | $6.61 (+27.12%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access